Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Long-Term Deferred Tax: 2021-2024

Historic Long-Term Deferred Tax for Collegium Pharmaceutical (COLL) over the last 4 years, with Dec 2024 value amounting to $98.0 million.

  • Collegium Pharmaceutical's Long-Term Deferred Tax rose 41.33% to $102.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.5 million, marking a year-over-year increase of 41.33%. This contributed to the annual value of $98.0 million for FY2024, which is 273.33% up from last year.
  • As of FY2024, Collegium Pharmaceutical's Long-Term Deferred Tax stood at $98.0 million, which was up 273.33% from $26.3 million recorded in FY2023.
  • Collegium Pharmaceutical's 5-year Long-Term Deferred Tax high stood at $98.0 million for FY2024, and its period low was $23.9 million during FY2022.
  • For the 3-year period, Collegium Pharmaceutical's Long-Term Deferred Tax averaged around $49.4 million, with its median value being $26.3 million (2023).
  • As far as peak fluctuations go, Collegium Pharmaceutical's Long-Term Deferred Tax plummeted by 69.31% in 2022, and later spiked by 273.33% in 2024.
  • Yearly analysis of 4 years shows Collegium Pharmaceutical's Long-Term Deferred Tax stood at $78.0 million in 2021, then slumped by 69.31% to $23.9 million in 2022, then grew by 9.64% to $26.3 million in 2023, then surged by 273.33% to $98.0 million in 2024.